The relationship between hepatic immunoglobulin production and CD154 expression in chronic liver diseases

Liver International

Volumn 26, Issue 2, 2006, Pages 187-196

  Mayo, Marlyn J ^a   Mosby, James M ^a   Jeyarajah, Rohan ^a   Combes, Burton ^a   Khilnani, Smina ^a   Al Halimi, Maha ^a   Handem, Iorna ^a   Grammer, Amrie C ^b   Lipsky, Peter E ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

CD154; CD40; CD40 ligand; Hyperglobulinemia; Immunoglobulin ; Immunoglobulin

Indexed keywords

CD40 LIGAND; COMPLEMENTARY DNA; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MESSENGER RNA; TUMOR NECROSIS FACTOR; URSODEOXYCHOLIC ACID;

ADULT; AGED; ALCOHOLIC FATTY LIVER; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; B LYMPHOCYTE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOGLOBULIN PRODUCTION; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

CD40 LIGAND; CHRONIC DISEASE; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LEUKOCYTES, MONONUCLEAR; LIVER; LIVER DISEASES; MALE; MIDDLE AGED; RNA, MESSENGER;

EID: 33645964951     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01211.x     Document Type: Article

References (15)

1. Doniach D, Roitt I M, Walker J G, Sherlock S. Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver disease and their clinical implication. Clin Exp Immunol 1966; 1: 237.
2. Feizi T. Immunoglobulins in chronic liver disease. Gut 1968; 9: 193-8.
3. Alvarez F, Berg P A, Bianchi B, Bianchi L, Burroughs A K, Cancado E L, et al. International autoimmune hepatitis group report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38.
4. Walker G, Doniach D. Antibodies and immunoglobulins in liver disease. Gut 1968; 9: 266-9.
5. Nouri-Aria K T, Hegarty J E, Neuberger J, Eddleston A, Williams R. In vitro studies on the mechanism of increased serum IgM levels in primary biliary cirrhosis. Clin Exp Immunol 1985; 61: 297-304.
6. Popper H, Paronetto F, Schaffner F. Immune processes in the pathogenesis of liver disease. Ann NY Acad Sci 1965; 124: 781-99.
7. Paronetto F, Schaffner F, Popper H. Immunocytochemical observations in primary biliary cirrhosis. N Engl J Med 1964; 271: 1123-8.
8. Montaverde A, Ballare M, Pileri S. Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia. Springer Semin Immunopathol 1997; 19: 99-110.
9. James S P, Elson C O, Jones A, Strober W. Abnormal regulation of immunoglobulin synthesis in vitro in primary biliary cirrhosis. Gastroenterology 1980; 79: 242-54.
10. Menendez-Carlo J L, Alvarez-Mon M, Giron J A, Manzano L, Garrido A, Abreu L, et al. Increased IgM B cell differentiation lymphokine production by T lymphocytes from patients with primary biliary cirrhosis. J Hepatol 1994; 20: 446-53.
11. Quezada S A, Jarvinen L Z, Lind E F, Noelle R J. CD40/;CD154 interactions at the interface of tolerance and immunity. Ann Rev Immunol 2004; 22: 307-28.
12. Bhushan A, Covey L R. CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes. Immunologic Res 2001; 24: 311-24.
13. Higuchi M, Horiuchi T, Kojima T, Nishizaka H, Ishibashi H, Hayashi K, et al. Analysis of CD40 ligand gene mutations in patients with primary biliary cirrhosis. Scan J Clin Lab Invest 1998; 58: 429-32.
14. Komura K, Sato S, Hasegawa M, Fujimoto M, Takehara K. Elevated circulating CD40L concentrations in patients with systemic sclerosis. J Rheumatol 2004; 31: 514-9.
15. Vakkalanka R K, Woo C, Kirou K A, Koshy M, Berger D, Crow M K. Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera. Arthritis Rheum 1999; 42: 871-81.